# Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)

Study · id `cardio:ct-nct07920055` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07920055](<https://clinicaltrials.gov/study/NCT07920055>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07920055

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 106 participants.

## Technical summary

Registry record NCT07920055. Randomized; no masking; primary purpose treatment. Start 2026-11-01 (anticipated); primary completion 2028-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 106 participants (planned count; ClinicalTrials.gov record NCT07920055, source copy `cardio:ctgov-nct07920055-2026-11-05`, retrieved 2026-11-18)
- Planned start: 2026-11-01 (anticipated) (ClinicalTrials.gov record NCT07920055, source copy `cardio:ctgov-nct07920055-2026-11-05`, retrieved 2026-11-18)
- Primary completion: 2028-08-31 (anticipated) (ClinicalTrials.gov record NCT07920055, source copy `cardio:ctgov-nct07920055-2026-11-05`, retrieved 2026-11-18)
- Completion: 2028-11-30 (anticipated) (ClinicalTrials.gov record NCT07920055, source copy `cardio:ctgov-nct07920055-2026-11-05`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT07920055, source copy `cardio:ctgov-nct07920055-2026-11-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07920055-2026-11-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
- Acronym: SPRIT
- Condition: Coronary In-stent Restenosis
- Condition: Coronary Artery Disease
- Intervention (Device): SeQuent SCB sirolimus-coated balloon
- Intervention (Drug): RESTORE DEB paclitaxel-coated balloon
- Lead sponsor: Sir Run Run Shaw Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Sir Run Run Shaw Hospital (`cardio:org-sir-run-run-shaw-hospital`)

## Provenance

Content hash: a6569ef90ce180e487f8fc2072c45eeed33266a15c2d67377db51d8edbdc43f0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
